Literature DB >> 28812598

Breast cancer: 10-year follow-up of the TEAM cohort reported.

Peter Sidaway.   

Abstract

Entities:  

Year:  2017        PMID： 28812598     DOI： 10.1038/nrclinonc.2017.133

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Adjuvant tamoxifen and exemestane in women with postmenopausal early breast cancer (TEAM): 10-year follow-up of a multicentre, open-label, randomised, phase 3 trial.

Authors:  Marloes G M Derks; Erik J Blok; Caroline Seynaeve; Johan W R Nortier; Elma Meershoek-Klein Kranenbarg; Gerrit-Jan Liefers; Hein Putter; Judith R Kroep; Daniel Rea; Annette Hasenburg; Christos Markopoulos; Robert Paridaens; Jan B E Smeets; Luc Y Dirix; Cornelis J H van de Velde
Journal:  Lancet Oncol       Date:  2017-07-18       Impact factor: 41.316
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.